Immune cell mediated cabozantinib resistance for patients with renal cell carcinoma is a research paper published in Integrative Biology (2021). On theSindex it has a DataRank of 0. It has been cited 10 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: T32HL110853
National Institutes of Health
Grant: 1S10RR025483–01
National Institutes of Health
Grant: R33CA225281
University of Wisconsin Carbone Cancer Center
Grant: P30 CA014520
NCRR NIH HHS
Grant: S10 RR025483
NCI NIH HHS
Grant: L30 CA111079
National Institutes of Health
Grant: 5P30CA014520-18
CANCER CENTER SUPPORT
National Institutes of Health
Grant: 5T32HL110853-10
Vascular Surgery Research Training Program
National Institutes of Health
Grant: 1R33CA225281-01
Area C: Functional microscale organotypic assays to predict patient response to anti-angiogenesis therapies
National Institutes of Health
Grant: 1S10RR025483-01
Multi-color Benchtop Flow Cytometer
FWCI
0.78
Citation Percentile
0.7%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals